Details for 2016708853

Up to date per 02.04.2026

Actions

Title / Product Name

DOSEN UND VERFAHREN ZUR VERABREICHUNG VON TELAVANCIN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016708853

EP Publication Number

3261658

E-Number

1114906

Language

PCT Number

US16018396

Publication Date

03.01.2018 A

03.04.2019 B1

Registration Date

03.04.2019

AT Publication Date

15.04.2019

Application Date

18.02.2016

Registration Number

Priorities

23.02.2015

201562119592 P

IPC

A61K 38/12 20060101AFI20170906BHEP

Maximum Duration of Protection

18.02.2036

Owner

Theravance Biopharma Antibiotics IP, LLC901, Gateway Boulevard South San Francisco, CA 94080US

Representative

No representatives present

Inventor

BARRIERE, Steven L.1660 Lyon Street San Francisco, California 94115US

LO, Arthur1485 46th Avenue San Francisco, California 94122US

MAMMEN, Mathai1852 Valparaiso Avenue Menlo Park, California 94025US

WORBOYS, Philip30 Chester Way San Mateo, California 94402US